Improving Primary Prevention of Coronary Artery Disease in Women using Breast Arterial
Calcifications seen on Screening Mammography
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Background

Proposed Intervention and Plan

• Cardiovascular disease (CVD)
remains the number one cause
of death and yet the mortality
rate for young women has
plateaued compared to men,
which is declining.

Task Force Roles
• PCPs determine
inclusion criteria of
patients who may
benefit from BAC
report

• ASCVD screening guidelines do
not always capture women with
CAD detectable by imaging.

• Breast Imagers
determine ideal way
to report presence of
BAC on screening
mammograms

• Coronary artery calcium scoring
by CT is costly, inconvenient
and exposes women to direct
chest wall radiation.

• Cardiologists and
PCPs collaborate to
determine course of
action following
report of positive
BAC: further labwork or diagnostic
imaging, statin
therapy or lifestyle
modification

• Our data supports breast
arterial calcifications (BAC)
seen on mammography as
specific marker for CAD.

Interdisciplinary Task Force

• In our retrospective review of
screening mammograms on 105
women aged 40-60, 22% had BAC
which was 92% specific for CAD on
chest CT.

Study Aims

Process Measurement

• To create an interdisciplinary task
force focused on identifying
women with CVD by reporting
presence of BAC on screening
mammograms.

• Quantify the percentage of screening
mammograms with BAC addressed in
final read.

• To monitor the clinical impact of
reporting BAC.

• Quantify the number of PCP and
patient interactions that discuss BAC
results.
• Quantify clinical outcomes based on
reporting BAC.

